Healthcare Finance News September 1, 2020
The proposed rule has been commended by the Advanced Medical Technology Association for getting innovative technology to patients that need them.
The Centers for Medicare and Medicaid Services issued a proposed rule this week that would give breakthrough medical devices national Medicare coverage on the same day they receive Food and Drug Administration approval.
The rule, called the Medicare Coverage of Innovative Technology (MCIT), would provide Medicare coverage of the devices for four years. During the four-year period, CMS recommends that manufacturers develop additional evidence showing the applicability of their products to Medicare beneficiaries so they can apply for further coverage.
To be eligible, a device must be designated by the FDA as a breakthrough, meaning it must provide more effective treatment...